Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C symptoms and diagnosis news

Show

From To
Hepatitis and HIV
Liver disease a possible predictor of stroke: Study

People suffering from fatty liver disease may be three times more likely to suffer a stroke than individuals without fatty liver, according to a study by researchers at St. Michael's Hospital and the London health Sciences Centre. The study is the first to find a link between nonalcoholic fatty liver disease -- a disease characterized by the accumulation of fat in the liver in non drinkers -- and stroke.

Published
07 January 2011
From
Eurekalert Medicine & Health
Hepatitis C symptoms and diagnosis
Rapid hepatitis C antibody tests show wide range of results

The first generation of rapid screening tests for the hepatitis C virus (HCV) antibody, which use blood and oral fluids, underwent field testing in September at 4 sites. The tests had considerable variation in performance across the 4 test sites, with wide ranges in sensitivity, specificity, positive predictive value, and negative predictive value.

Published
17 November 2010
From
Medscape
Hepatitis C symptoms and diagnosis
Liver Cancer Survival Similar in HIV-Positive and HIV-Negative People

Three-year survival rates after a diagnosis of hepatocellular carcinoma (liver cancer) are similar between people living with HIV and HIV-negative people, according to a study presented at the American Association for the Study of Liver Diseases being held October 29 to November 2 in Boston.

Published
09 November 2010
From
AIDSMeds
Hepatitis C symptoms and diagnosis
Isentress Might Reduce Risk of a “Fatty” Liver From Protease Inhibitors

A new laboratory study suggests that the integrase inhibitor Isentress (raltegravir) could prevent the accumulation of excess fat in the liver (steatosis) that results from protease inhibitor (PI) therapy. These data were presented at the 61st Annual Meeting of the American Association for the Study of Liver Diseases, held October 29 to November 2 in Boston.

Published
04 November 2010
From
Poz magazine news
← Prev1...1112131415Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.